Slimane Ait-Si-Ali

Title: Slimane Ait-Si-Ali: Innovator in Cancer Treatment

Introduction

Slimane Ait-Si-Ali is a prominent inventor based in Villejuif, France. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Ait-Si-Ali is recognized for his work in developing targeted therapies that aim to combat cancer at the molecular level.

Latest Patents

Ait-Si-Ali's latest patents include groundbreaking advancements in the treatment of cancer. One of his notable inventions is a SiRNA-based cancer treatment, which involves a double-strand oligonucleotide that includes two complementary oligonucleotide sequences forming a hybrid. This hybrid is designed to specifically repress a target sequence belonging to a DNA or RNA molecule associated with angiogenic factors. Another significant patent focuses on inhibitor oligonucleotides and their use for the specific repression of harmful genes. This method involves administering a therapeutically effective amount of a pharmaceutical composition containing double-stranded oligonucleotides that target mutated or nonmutated androgen receptors.

Career Highlights

Slimane Ait-Si-Ali is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research and develops his innovative therapies. His work has garnered attention in the scientific community, contributing to advancements in cancer treatment methodologies.

Collaborations

Ait-Si-Ali has collaborated with esteemed colleagues such as Florence Cabon-Georget and Annick Harel-Bellan. These collaborations have further enriched his research and have played a vital role in the development of his patented technologies.

Conclusion

Slimane Ait-Si-Ali is a distinguished inventor whose work in cancer treatment is paving the way for innovative therapeutic approaches. His contributions to the field are significant and continue to inspire advancements in medical research.